ALNY
ALNYLAM PHARMACEUTICALS, INC.
+1.31 (+0.55%)240.68USD291K成交股數32.2B市值65.4本益比(近四季)7.3股價營收比+66.9%營收年增(近四季)2026-10-29下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 1.3B+117% | – | 1.2B+149% | 774M+17% | 594M+20% | 593M-21% | 501M+57% | 660M+107% | 494M | 751M | 319M | 319M |
| 營業成本 | 298M | – | 197M | 142M | 70.2M | 103M | 82.0M | 67.3M | 54.6M | 79.5M | 75.3M | 41.4M |
| 毛利 | 993M+89% | – | 1.1B+151% | 632M+7% | 524M+19% | 491M-27% | 419M+72% | 593M+113% | 440M | 671M | 243M | 278M |
| 毛利率 | 76.9% | – | 84.2% | 81.6% | 88.2% | 82.7% | 83.6% | 89.8% | 89.0% | 89.4% | 76.4% | 87.0% |
| 研發費用 | 413M | – | 359M | 324M | 265M | 300M | 271M | 294M | 261M | 253M | 249M | 231M |
| 銷售管理費用 | 348M | – | 322M | 323M | 240M | 295M | 221M | 248M | 211M | 199M | 215M | 184M |
| 營業利益 | 231M+1180% | – | 368M-578% | −16.2M-133% | 18.1M-142% | −105M-149% | −76.9M-67% | 48.6M-132% | −43.4M | 214M | −230M | −150M |
| 營業利益率 | 17.9% | – | 29.5% | -2.1% | 3.0% | -17.7% | -15.4% | 7.4% | -8.8% | 28.5% | -72.1% | -46.9% |
| 稅後淨利 | 164M-1001% | 206M-346% | 251M-325% | −72.2M+328% | −18.3M-72% | −83.8M-157% | −112M-60% | −16.9M-90% | −65.9M | 148M | −276M | −174M |
| 淨利率 | 12.7% | – | 20.1% | -9.3% | -3.1% | -14.1% | -22.3% | -2.6% | -13.3% | 19.7% | -86.6% | -54.5% |
| 稀釋 EPS | 1.21-964% | – | 1.84-311% | -0.55+323% | -0.14-73% | -0.66-157% | -0.87-61% | -0.13-91% | -0.52 | 1.15 | -2.21 | -1.40 |
| 稀釋股數 | 138M | – | 137M | 131M | 130M | 128M | 129M | 127M | 126M | 131M | 125M | 124M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 1.7B | – | 1.5B | 1.1B | 1.0B | 966M | 1.1B | 968M | 682M | 1.0B | 658M | 672M |
| 應收帳款 | 913M | – | 965M | 567M | 418M | 405M | 354M | 309M | 321M | 325M | 221M | 219M |
| 存貨 | 97.1M | – | 75.4M | 71.7M | 65.6M | 78.5M | 76.0M | 84.0M | 94.0M | 95.8M | 100M | 132M |
| 總資產 | 5.6B | – | 4.9B | 4.6B | 4.2B | 4.2B | 4.2B | 4.0B | 3.8B | 3.8B | 3.4B | 3.4B |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 4.2B | – | 4.6B | 4.3B | 4.1B | 4.2B | 4.2B | 4.0B | 4.0B | 4.0B | 3.8B | 3.7B |
| 股東權益 | 1.4B | 1.1B | 234M | 555M | 426M | 67.1M | 32.4M | −3.1M | −219M | −166M | −408M | −259M |
| 負債比 | 75.6% | – | 95.2% | 94.5% | 97.3% | 98.4% | 99.2% | 100.1% | 105.7% | 104.3% | 112.0% | 107.6% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | – | – | – | −118M+45% | – | – | – | −81.5M | – | – | −166M |
| 資本支出 | – | – | – | – | 9.0M | – | – | – | 13.0M | – | – | 13.9M |
| 自由現金流 | – | – | – | – | −127M+35% | – | – | – | −94.5M | – | – | −180M |
| 折舊攤銷 | – | – | – | – | 14.4M | – | – | – | 13.5M | – | – | 14.1M |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | -21.4% | – | – | – | -19.1% | – | – | -56.5% |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
產品／服務2025 年度 · 3.7B
| Amvuttra | 2.3B | 62.3% | +138.4% |
|---|---|---|---|
| Collaborations | 553M | 14.9% | +8.5% |
| GIVLAARI | 308M | 8.3% | +20.6% |
| OXLUMO | 191M | 5.2% | +14.6% |
| Royalty | 174M | 4.7% | +89.6% |
| ONPATTRO | 173M | 4.7% | -31.7% |
| 產品 小計 | 3.0B | 80.4% | +81.4% |
| TTR 小計 | 2.5B | 67.0% | +103.3% |
| Rare 小計 | 500M | 13.5% | +18.2% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 3.7B | +65.2% | 314M | 8.4% | 2.33 | 465M |
| FY2024 | 2.2B | +23.0% | −278M | -12.4% | -2.18 | −42.6M |
| FY2023 | 1.8B | +76.2% | −440M | -24.1% | -3.52 | 41.9M |
| FY2022 | 1.0B | +22.9% | −1.1B | -109.0% | -9.30 | −613M |
| FY2021 | 844M | +71.3% | −853M | -101.0% | -7.20 | −718M |
| FY2020 | 493M | +124.3% | −858M | -174.1% | -7.46 | −685M |
| FY2019 | 220M | +193.4% | −886M | -403.2% | -8.11 | −419M |
| FY2018 | 74.9M | – | −761M | -1,016.6% | -7.57 | −690M |